Literature DB >> 19041749

Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells.

Kartik Venkatachalam1, A Ashleigh Long, Rebecca Elsaesser, Daria Nikolaeva, Kendal Broadie, Craig Montell.   

Abstract

Disruption of the Transient Receptor Potential (TRP) mucolipin 1 (TRPML1) channel results in the neurodegenerative disorder mucolipidosis type IV (MLIV), a lysosomal storage disease with severe motor impairments. The mechanisms underlying MLIV are poorly understood and there is no treatment. Here, we report a Drosophila MLIV model, which recapitulates the key disease features, including abnormal intracellular accumulation of macromolecules, motor defects, and neurodegeneration. The basis for the buildup of macromolecules was defective autophagy, which resulted in oxidative stress and impaired synaptic transmission. Late-apoptotic cells accumulated in trpml mutant brains, suggesting diminished cell clearance. The accumulation of late-apoptotic cells and motor deficits were suppressed by expression of trpml(+) in neurons, glia, or hematopoietic cells. We conclude that the neurodegeneration and motor defects result primarily from decreased clearance of apoptotic cells. Since hematopoietic cells in humans are involved in clearance of apoptotic cells, our results raise the possibility that bone marrow transplantation may limit the progression of MLIV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041749      PMCID: PMC2649760          DOI: 10.1016/j.cell.2008.09.041

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  52 in total

1.  Role and regulation of starvation-induced autophagy in the Drosophila fat body.

Authors:  Ryan C Scott; Oren Schuldiner; Thomas P Neufeld
Journal:  Dev Cell       Date:  2004-08       Impact factor: 12.270

Review 2.  Methods for monitoring autophagy.

Authors:  Noboru Mizushima
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

Review 3.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

4.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

Authors:  J M Warrick; H Y Chan; G L Gray-Board; Y Chai; H L Paulson; N M Bonini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

Review 6.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

7.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

8.  Interaction of stoned and synaptotagmin in synaptic vesicle endocytosis.

Authors:  T Fergestad; K Broadie
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

9.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

10.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

View more
  111 in total

1.  The Drosophila TRPP cation channel, PKD2 and Dmel/Ced-12 act in genetically distinct pathways during apoptotic cell clearance.

Authors:  Emeline Van Goethem; Elizabeth A Silva; Hui Xiao; Nathalie C Franc
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

2.  Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy.

Authors:  David A Zeevi; Shaya Lev; Ayala Frumkin; Baruch Minke; Gideon Bach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV.

Authors:  Soonhong Park; Malini Ahuja; Min Seuk Kim; G Cristina Brailoiu; Archana Jha; Mei Zeng; Maryna Baydyuk; Ling-Gang Wu; Christopher A Wassif; Forbes D Porter; Patricia M Zerfas; Michael A Eckhaus; Eugen Brailoiu; Dong Min Shin; Shmuel Muallem
Journal:  EMBO Rep       Date:  2015-12-18       Impact factor: 8.807

5.  Inhibition of Transient Receptor Potential Channel Mucolipin-1 (TRPML1) by Lysosomal Adenosine Involved in Severe Combined Immunodeficiency Diseases.

Authors:  Xi Zoë Zhong; Yuanjie Zou; Xue Sun; Gaofeng Dong; Qi Cao; Aditya Pandey; Jan K Rainey; Xiaojuan Zhu; Xian-Ping Dong
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

6.  A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis.

Authors:  Mohammad Samie; Xiang Wang; Xiaoli Zhang; Andrew Goschka; Xinran Li; Xiping Cheng; Evan Gregg; Marlene Azar; Yue Zhuo; Abigail G Garrity; Qiong Gao; Susan Slaugenhaupt; Jim Pickel; Sergey N Zolov; Lois S Weisman; Guy M Lenk; Steve Titus; Marthe Bryant-Genevier; Noel Southall; Marugan Juan; Marc Ferrer; Haoxing Xu
Journal:  Dev Cell       Date:  2013-08-29       Impact factor: 12.270

Review 7.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

8.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

9.  Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.

Authors:  Ching-On Wong; Michela Palmieri; Jiaxing Li; Dmitry Akhmedov; Yufang Chao; Geoffrey T Broadhead; Michael X Zhu; Rebecca Berdeaux; Catherine A Collins; Marco Sardiello; Kartik Venkatachalam
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

Review 10.  Aberrant Ca2+ handling in lysosomal storage disorders.

Authors:  Kirill Kiselyov; Soichiro Yamaguchi; Christopher W Lyons; Shmuel Muallem
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.